about
VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancerVaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signalingModulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold proteinThe subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell linesVaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signalingp53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loopNSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAsPost-transcriptional modifications in development and stem cellsThe mouse cytosine-5 RNA methyltransferase NSun2 is a component of the chromatoid body and required for testis differentiationDeficient methylation and formylation of mt-tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage responseCharacterizing 5-methylcytosine in the mammalian epitranscriptome.Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndromeAberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.Role of RNA methyltransferases in tissue renewal and pathologyIdentification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations.Novel RNA modifications in the nervous system: form and functionThe opposing transcriptional functions of Sin3a and c-Myc are required to maintain tissue homeostasis.Posttranscriptional methylation of transfer and ribosomal RNA in stress response pathways, cell differentiation, and cancerStem cell function and stress response are controlled by protein synthesis.Cytosine-5 RNA Methylation Regulates Neural Stem Cell Differentiation and MotilityThe histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.The RNA-methyltransferase Misu (NSun2) poises epidermal stem cells to differentiate.The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas.The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism.Human TSG101 does not replace Saccharomyces cerevisiae VPS23 role in the quality control of plasma membrane proteins.Considerations for skin carcinogenesis experiments using inducible transgenic mouse models.SnapShot: Messenger RNA ModificationsEmerging roles of novel small non-coding regulatory RNAs in immunity and cancerPost-transcriptional regulation by cytosine-5 methylation of RNAEpigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational programCytosine-5 RNA methylation links protein synthesis to cell metabolism
P50
Q24294283-C697FA30-D202-41B7-A93F-05308F584619Q24297063-5B6FBD0E-1EFE-460D-9A27-A96008A5663EQ24315684-0631F216-B082-41D9-AEE5-FE6E5ADA1B3AQ24337220-7AD3CA88-7268-4B91-AB57-04B90C692284Q24337845-24F4A93E-E0A6-4343-B33E-DEE6F829CF39Q24339458-E8FB212D-E6F9-47CF-BF86-A1EECB1A2D49Q24548984-564B13DB-487A-439B-91C2-FB15AE03C02BQ24634597-19972BC7-8D93-4D17-A8A4-DCDA644303B6Q28075216-B38F01E1-6D76-4FC2-BCA2-FA371EA218E5Q28510091-B878C522-542D-4B06-9FBC-FFA0E848032BQ28596578-C56DFF87-890C-494A-A4D6-38F9BA49E077Q31034658-2B3327AB-E9FF-46DE-8C29-6C24FADE56AAQ33350162-9493A3DE-BFE9-4F86-8CB3-2982FA7B1DAEQ33688463-CEFD1F6A-6C9E-453E-B2BB-EFCF4C7D38D4Q33741852-7C06C0BE-430C-4DD0-9620-421781B27C5EQ34274157-E94CB960-F996-4FD3-83C3-EC75D3BF6CC7Q34332444-27B45498-31B2-406C-ADEC-470EB56788EAQ34549119-3FF5EC3C-40A1-46EE-9197-59A27C053B8FQ34647159-7133CE29-A2C1-4349-862D-DFAA2FCD3EB0Q35473380-171723B0-1E79-4671-8F72-8F801F370F43Q35622220-2C054815-9119-4718-816E-9055909E363EQ36722453-F95DC72E-A0EA-4402-AA03-7CA30E86CAC2Q37292813-159CA11B-F32C-43F4-A92B-CC5681795483Q37583656-A6A1628F-C63D-49A1-A8DA-62CF82A247B3Q38329989-90EFC975-A9F8-4184-8B04-C08AF448B878Q39537765-9AC2D8B2-849C-42E4-90B8-80C232E579B8Q39893596-CB5666FB-408A-4305-B3BE-A06C92D537C8Q40095899-6C9D75AA-9ABE-435A-8752-C3189545719DQ40508316-F3D8EEA5-C65A-4CDE-A79A-4B59F11A0BBEQ44426295-89F29C8D-1E30-475C-8EAD-C6DA5375FA6EQ48181813-C2BA7364-C9FD-4DFA-ACA2-A0FA8B0A49CDQ90210873-8A5BEF98-9EED-48F3-8BC2-DAAD7AEB845CQ90422329-A843C838-D342-4CD4-A07C-9719823EA360Q90799866-AABE400F-37AD-4BFB-8809-EBFEFAFBDB71Q92718047-288B01FB-2DEB-4EAB-A362-A7386FDC765CQ92751168-98363985-9444-4CFA-8869-5232BFD9744A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sandra Blanco
@ast
Sandra Blanco
@en
Sandra Blanco
@es
Sandra Blanco
@nl
Sandra Blanco
@sl
type
label
Sandra Blanco
@ast
Sandra Blanco
@en
Sandra Blanco
@es
Sandra Blanco
@nl
Sandra Blanco
@sl
prefLabel
Sandra Blanco
@ast
Sandra Blanco
@en
Sandra Blanco
@es
Sandra Blanco
@nl
Sandra Blanco
@sl
P1053
B-2070-2017
P106
P108
P21
P31
P3829
P496
0000-0001-7352-9392